[CAMBREX LOGO]

News Release


Date:      August 2, 2006
Contact:   Anne-Marie Hess
           Sr. Director, Investor Relations & Corporate Communications
Phone:     201-804-3062
Email:     annemarie.hess@cambrex.com
Release:   Immediate


      GARY L. MOSSMAN, EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER,
                              ANNOUNCES RETIREMENT

     East Rutherford, NJ - August 2, 2006 - Cambrex Corporation (NYSE: CBM)
announces that Gary L. Mossman, Executive Vice President, Chief Operating
Officer and President Cambrex Pharma, will retire effective August 31, 2006.
Upon Mr. Mossman's retirement, Steven M. Klosk, Executive Vice President and
Chief Operating Officer - Biopharma will assume responsibility for the Pharma
business. Paulo Russolo, President - Cambrex Profarmaco, Shawn Cavanagh, Sr.
Vice President and General Manager - Bioproducts and Steven M. Klosk, Executive
Vice President and Chief Operating Officer - Biopharma & Pharma will report
directly to James A. Mack, Chairman, President and Chief Executive Officer.

     Mr. Mack commented, "We were fortunate to have had Gary's experience and
leadership over the last 3 1/2 years and he leaves the business extraordinarily
well positioned for continued success in the years to come. We wish him all the
best in his retirement."

About Cambrex

     Cambrex is a global, diversified life sciences company dedicated to
providing products and services to accelerate and improve the discovery and
commercialization of human therapeutics. The Company employs approximately 2,000
worldwide. For more information, please visit www.cambrex.com.

                                      # # #

Cambrex Corporation | One Meadowlands Plaza | East Rutherford, NJ 07073
Phone 201.804.3000 | Fax 201.804.9852 | www.cambrex.com